Document:

Exhibit 4.4

   

  FORM OF PRE-FUNDED COMMON SHARE PURCHASE WARRANT

   

  UNITED MARITIME CORPORATION

   

  	Warrant Shares: 

          	Issue Date:                     

          

  CUSIP: 

  

  ISIN: 

  

   

  THIS PRE-FUNDED COMMON SHARE
    PURCHASE WARRANT (this “Warrant”) certifies that, for value received, ________, or its assigns (the “Holder”),
    is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
    the date hereof (the “Issue Date”), and until this Warrant is exercised in full (the “Termination Date”)
    but not thereafter, to subscribe for and purchase from United Maritime Corporation, a corporation incorporated under the laws of the Republic
    of the Marshall Islands (the “Company”), up to                     Common Shares (as subject to adjustment hereunder, the “Warrant
      Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Aggregate Exercise Price, as defined
    in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository
    Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s
    right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence
    shall not apply.

   

  Section 1.               Definitions.
    In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

   

  “Affiliate”
    means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
    with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

   

  “Bid Price”
    means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed
    or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding date) on the Trading
    Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New
    York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of
    the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then
    listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market. (or a similar
    organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d)
    in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the Holders
    of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
    be paid by the Company.

   

  “Business
      Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
    or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized
    or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” 
    or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
    so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
    are open for use by customers on such day.

   

  
  
    	 	 	 

  

  
     

  

  
    

  “Commission”
    means the United States Securities and Exchange Commission.

   

  “Common
      Shares” means the common shares of the Company, par value $0.0001 per share, and any other class of securities into which such
    securities may hereafter be reclassified or changed. 

   

  “Common
      Share Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
    at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
    at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.

   

  “Exchange
      Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

   

  “Person”
    means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
    joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

   

  “Purchase
      Agreement” means the Securities Purchase Agreement, dated as of July 18, 2022 among the Company and certain purchasers signatory
    thereto, as amended, modified or supplemented from time to time in accordance with its terms.

   

  “Registration
      Statement” means the Company’s registration statement on Form F-1 (File No. 333-266099).

   

  “Securities
      Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

   

  “Subsidiary”
    means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where applicable, also include any direct
    or indirect subsidiary of the Company formed or acquired after the date hereof.

   

  “Trading
      Day” means a day on which the Common Shares are traded on a Trading Market.

   

  “Trading
      Market” means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date
    in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
    Exchange (or any successors to any of the foregoing).

   

  “Transfer
      Agent” means American Stock Transfer & Trust Company, LLC, the current transfer agent of the Company with a mailing address
    of 6201 15th Avenue, Brooklyn, New York 11219, and any successor transfer agent of the Company.

    

  
  
    	 	 	 

  

  
     

  

  
    

  “VWAP”
    means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed
    or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date)
    on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from
    9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
    average price of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares
    are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market
    (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported,
    or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by
    the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
    of which shall be paid by the Company. 

   

  “Warrant
      Agency Agreement” means that certain warrant agency agreement, dated on or about the Issue Date, between the Company and the
    Warrant Agent.

   

  “Warrant
      Agent” means the Transfer Agent or its affiliate that acts as warrant agent and any successor warrant agent of the Company.

   

  “Warrants”
    means this Warrant and all other Pre-Funded Common Share Purchase Warrants issued by the Company pursuant to the Registration Statement.

   

  Section 2.               Exercise.

   

  a)             Exercise
      of Warrant. Subject to the provisions of Section 2(e) hereof, exercise of the purchase rights represented by this Warrant may be made,
    in whole or in part, at any time or times on or after the Issue Date and on or before the Termination Date by delivery to the Company
    of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice
      of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
    Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
    Price for the shares specified in the applicable Notice of Exercise by wire transfer unless the cashless exercise procedure specified
    in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
    any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
    to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
    of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
    to the Company for cancellation within five (5) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
    Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
    have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
    of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
    date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
    notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of
      this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
      hereunder at any given time may be less than the amount stated on the face hereof.

   

  
  
    	 	 	 

  

  
     

  

  
    

  Notwithstanding
    the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
    Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises
    made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction
    form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable),
    subject to a Holder’s right to elect to receive a Definitive Certificate pursuant to the terms of the Warrant Agency Agreement,
    in which case this sentence shall not apply. The Company hereby acknowledges and agrees that, with respect to a holder whose interest
    in this Warrant is a beneficial interest, upon delivery of irrevocable instructions to such holder’s DTC Participant to exercise
    such warrants, that solely for purposes of Regulation SHO that such holder shall be deemed to have exercised such warrants. Notwithstanding
    anything to the contrary contained herein, a beneficial holder of the Warrant shall have all of the rights and remedies of the “Holder”
    hereunder.

   

  b)            Exercise
      Price The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share (the “Aggregate
      Exercise Price”), was pre-funded to the Company on or prior to the Issue Date and, consequently, no additional consideration
    (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect
    any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of the pre-paid Aggregate
    Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised
    prior to the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment
    hereunder (the “Exercise Price”).

   

  c)             Cashless
      Exercise. This Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which
    the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where: 

   

  		(A) =	as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
          of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
          Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading
          hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at
          the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or
          (z) the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s
          execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a
          Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading
          hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the
          date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
          after the close of “regular trading hours” on such Trading Day;

   

  		(B) =	the Exercise Price of this Warrant, as adjusted hereunder; and

   

  		(X) =	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the
          terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

   

  
  
    	 	 	 

  

  
     

  

  
    

  If Warrant Shares
    are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
    the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
    contrary to this Section 2(c).

   

  d)            Mechanics
      of Exercise. 

   

  i.      Delivery
      of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
    Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company
    through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either
    (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
    Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in
    the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
    entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of
    (i) two (2) Trading Days after the delivery to the Company or the Warrant Agent of the Notice of Exercise, provided that payment of the
    aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company one (1) Trading Day prior to such
    second Trading Day after the delivery of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
    to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company or the
    Warrant Agent of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless
    exercise) is received by the Company one (1) Trading Day prior to such number of Trading Days comprising the Standard Settlement Period
    after the delivery of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of
    Exercise, the Holder shall be deemed, solely for purposes of Regulation SHO under the Securities Act, to have become the holder of record
    of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
    provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
    (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
    of Exercise. If the Company fails for any reason to deliver or cause the delivery to the Holder the Warrant Shares subject to a Notice
    of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
    for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice
    of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for
    each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The
    Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and
    exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading
    Days, on the Company’s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice
    of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City
    time) on the Issue Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees
    to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Issue Date and the Issue Date shall be
    the Warrant Share Delivery Date for purposes hereunder. Notwithstanding anything to the contrary contained herein, the Company shall not
    be required to deliver any Common Shares upon a cash exercise of a Warrant unless or until the aggregate Exercise Price with respect to
    such exercise has been delivered to the Company.

   

  
  
    	 	 	 

  

  
     

  

  
    

  ii.     Delivery
      of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
    upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver or cause the Warrant Agent to deliver
    to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
    which new Warrant shall in all other respects be identical with this Warrant.

   

  iii.    Rescission
      Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
    by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

   

  iv.   Compensation
      for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if
    the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
    2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than as a result of failure of the Holder to
    timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a cashless exercise), and if after such
    date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm
    otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
    receiving upon such exercise (a “Buy-In”), then the Company shall (A) provided that such price set forth in (y)(2)
    of this clause (A) is on market terms, pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price
    (including brokerage commissions, if any) for the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number
    of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
    at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
    portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
    be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied
    with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Shares having a total purchase price
    of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase Common Shares with an aggregate sale price
    giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required
    to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
    of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right
    to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
    and/or injunctive relief with respect to the Company’s failure to timely deliver Common Shares upon exercise of the Warrant as required
    pursuant to the terms hereof. 

   

  
  
    	 	 	 

  

  
     

  

  
    

  v.     No
      Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
    Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall
    round down to the nearest whole share.

   

  vi.   Charges,
      Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
    expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
    Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
    that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
    exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
    thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
    fees required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established clearing
    corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

   

  vii.   Closing
      of Books. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
    pursuant to the terms hereof. 

   

  
  
    	 	 	 

  

  
     

  

  
    

  e)             Holder’s
      Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
    any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
    as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting
    as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
    would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
    number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common
    Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of
    Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the
    Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any
    other securities of the Company (including, without limitation, any other Common Share Equivalents) subject to a limitation on conversion
    or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
    For purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the
    rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
    such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required
    to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
    this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
    and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
    shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by
    the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
    to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination,
    and a submission of a Notice of Exercise shall be deemed a representation and warranty by the Holder of the foregoing determination. In
    addition, a determination by the Holder as to any group status as contemplated above shall be determined in accordance with Section 13(d)
    of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the total
    number of outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company’s
    most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
    or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. Upon the
    written request of a Holder, the Company shall within one Trading Day confirm in writing to the Holder the number of Common Shares then
    outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise
    of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
    such number of outstanding Common Shares was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon
    election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of Common Shares outstanding immediately after giving
    effect to the issuance of Common Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or
    decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation shall
    in no event exceed 9.99% of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares upon
    exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial
    Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions
    of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e)
    in order to correct this paragraph (or any portion hereof), if necessary, which may be defective or inconsistent with the intended Beneficial
    Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
    The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

   

  Section 3.               Certain Adjustments.

   

  a)             Stock
      Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
    a distribution or distributions on Common Shares or any other common equity equivalent securities payable in Common Shares (which, for
    avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
    Common Shares into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into
    a smaller number of shares, or (iv) issues by reclassification of Common Shares any shares of capital stock of the Company, then in each
    case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury
    shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Common Shares outstanding
    immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
    the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective
    immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become
    effective immediately after the effective date in the case of a subdivision, combination or re-classification.  

   

  
  
    	 	 	 

  

  
     

  

  
    

  b)             Subsequent
      Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
    sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
    of any class of Common Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms
    applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
    of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
    limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale
    of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined
    for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate
    in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
    to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right
    to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right
    thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). 

    

  c)             Pro
      Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
    of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise (including, without
    limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
    corporate rearrangement, scheme of arrangement or other similar transaction) (except to the extent an adjustment was already made pursuant
    to Section 3(a)) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder
    shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
    had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
    hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for
    such Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the
    participation in such Distribution (provided, however, that, to the extent that the Holder’s right to participate
    in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
    to participate in such Distribution to such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution
    to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
    as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

    

  
  
    	 	 	 

  

  
     

  

  
    

  d)             Fundamental
      Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, other than in the ordinary
    course of business, in one or more related transactions effects any merger or consolidation of the Company with or into another Person,
    (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
    transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, except
    to the extent subject to an adjustment pursuant to Section 3(a), (b) or (c), (iii) any, direct or indirect, purchase offer, tender offer
    or exchange offer by the Company is completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their
    shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv)
    the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
    of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged
    for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a
    stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
    merger, or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
    the outstanding Common Shares (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the
    Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
    occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise
    of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
    and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by
    a holder of the number of Common Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
    regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
    Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
    issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
    Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
    If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
    the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
    Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
    (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance with
    the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
    by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
    Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
    and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
    its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations
    on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
    to such shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction
    and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
    protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction) and which is reasonably
    satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
    succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring
    to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
    assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the
    Company herein.

   

  
  
    	 	 	 

  

  
     

  

  
    

  e)             Calculations.
    All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
    of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of
    Common Shares (excluding treasury shares, if any) issued and outstanding.

   

  f)              Notice
      to Holder.

   

  i.      Adjustment
      to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
    deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
    to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

   

  ii.     Notice
      to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
    Shares, except for any recurring cash dividend (B) the Company shall declare a redemption of the Common Shares, (C) the Company shall
    authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital stock
    of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification
    of the Common Shares, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
    the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property,
    or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
    then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email
    address as it shall appear upon the Warrant Register of the Company, at least ten (10) calendar days prior to the applicable record or
    effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
    distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares
    of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
    such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
    as of which it is expected that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities,
    cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that
    the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
    required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
    information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
    to a Current Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of
    such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. 

   

  
  
    	 	 	 

  

  
     

  

  
    

  Section 4.               Transfer
      of Warrant.

   

  a)             Transferability.
    This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of
    the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
    executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
    Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
    assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
    to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
    anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
    has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within five (5) Trading Days
    of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned
    in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

   

  b)             New
      Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined
    with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
    and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section
    4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
    Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers
    or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number
    of Warrant Shares issuable pursuant thereto.

   

  c)             Warrant
      Register. The Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate (as defined in the Warrant Agency
    Agreement), the Company) shall register this Warrant, upon records to be maintained by the Warrant Agent (or, in the event a Holder elects
    to receive a Definitive Certificate, the Company) for that purpose (the “Warrant Register”), in the name of the record
    Holder hereof from time to time. The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute
    owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice
    to the contrary.

   

  Section 5.               Miscellaneous.

   

  a)             No
      Rights as Shareholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
    or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
    forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to
    Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
    to net cash settle an exercise of this Warrant. 

   

  b)             Loss,
      Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
    to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
    of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
    the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
    and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

   

  
  
    	 	 	 

  

  
     

  

  
    

  c)             Saturdays,
      Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
    herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

   

  d)             Authorized
      Shares.

   

  The Company covenants
    that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient number
    of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
    covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
    necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
    as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
    or of any requirements of the Trading Market upon which the Common Shares may be listed. The Company covenants that all Warrant Shares
    which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
    by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
    and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
    transfer occurring contemporaneously with such issue).

   

  Except and to the
    extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares
    underlying such Warrants), the Company shall not by any action, including, without limitation, amending its articles of incorporation
    or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
    action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith
    assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
    of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
    increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in
    par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
    paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
    authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
    Company to perform its obligations under this Warrant.

   

  Before taking any
    action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
    the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
    body or bodies having jurisdiction thereof. 

   

  
  
    	 	 	 

  

  
     

  

  
    

  e)             Governing
      Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
    construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
    law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
    contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
    partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
    Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
    of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
    herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
    subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
    Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
    by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
    in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
    notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
    by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
    such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and
    expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting
    the foregoing, the Company has confirms that it has appointed Watson Farley & Williams LLP, with a business address at 250 West 55th
    Street, 31st Floor, New York, NY 10019, as its authorized agent (the “Authorized Agent”) upon whom process
    may be served in any suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated herein which
    may be instituted in any New York federal or state court, by a Holder, the directors, officers, partners, employees and agents of such
    Holder and each affiliate of such Holder, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such
    suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has
    agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and
    all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes
    and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect,
    effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company
    shall appoint, without unreasonable delay, another such agent in the United States, and notify the Holders of such appointment. Notwithstanding
    the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
    the federal securities laws. This paragraph shall survive any termination of this Warrant, in whole or in part.

   

  f)              Restrictions.
    The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
    utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

   

  g)             Nonwaiver
      and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
    a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this
    Warrant, if it is finally adjudicated (without possibility of appeal) that the Company has willfully and knowingly failed to comply with
    any provision of this Warrant, which has resulted in any material damages to the Holder, the Company shall pay to the Holder such amounts
    as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those
    of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
    powers or remedies hereunder. 

   

  
  
    	 	 	 

  

  
     

  

  
    

  h)             Notices.
    Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
    of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized overnight courier service,
    addressed to:

   

  If to the Warrant Agent

   

  American Stock Transfer & Trust Company, LLC

  6201 15th Avenue

  Brooklyn, New York 11219

  Attention: Reorg Department - Warrants

  Email address: reorg_warrants@astfinancial.com

    

  If to the Company

   

  United Maritime Corporation

  154 Vouliagmenis Avenue

  166 74 Glyfada

  Greece

  Tel: + 30-2130181507

  Email: legal@usea.gr

  Facsimile: +302109638404

  Attn: General Counsel

   

  or such other facsimile number, email address
    or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries
    to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally
    recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address or address of such Holder appearing
    on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
    of (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail (or e-mail
    attachment) at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading
    Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile
    number or e-mail (or e-mail attachment) at the e-mail address as set forth on the signature pages attached hereto on a day that is not
    a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of
    mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is
    required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding
    the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on
    Form 6-K.

    

  i)              Limitation
      of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
    Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
    price of any Common Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the
    Company.

   

  j)              Remedies.
    The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to seek
    specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for
    any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense
    in any action for specific performance that a remedy at law would be adequate.

   

  
  
    	 	 	 

  

  
     

  

  
    

  k)             Successors
      and Assigns. Subject to applicable securities laws and the terms hereof, this Warrant and the rights and obligations evidenced hereby
    shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
    assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
    shall be enforceable by the Holder or holder of Warrant Shares.

   

  l)              Amendment.
    Any Warrant held in the form of a Definitive Certificate may be modified or amended or the provisions hereof waived with the written consent
    of the Company, on the one hand, and the Holder, on the other hand.

   

  m)            Severability.
    Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
    but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
    extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

   

  n)             Headings.
    The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

   

  o)             Warrant
      Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
    to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency
    Agreement, the provisions of this Warrant shall govern and be controlling. Any reference to the Company is also deemed to refer to the
    Warrant Agent, unless otherwise specified or the context otherwise requires.

   

  ********************

   

  (Signature Page Follows)

   

  
  
    	 	 	 

  

  
     

  

  
    

  IN WITNESS WHEREOF, the Company has caused this
    Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

   

  	 	UNITED MARITIME CORPORATION
	 	 	 
	 	By:	 
	 	 	Name: Stamatios Tsantanis
	 	 	Title:   Chairman and Chief Executive Officer

   

  
  
    	 	 	 

  

  
     

  

  
    

  NOTICE OF EXERCISE

   

  TO: UNITED MARITIME CORPORATION

   

  (1)   The undersigned
    hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only required if exercised
    in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

   

  (2)   Payment shall take the form of (check
    applicable box):

   

   ̈ in
      lawful money of the United States by wire transfer; or

   

   ̈
    if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula
      set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the
      cashless exercise procedure set forth in subsection 2(c).

   

  (3)   Please issue
    said Warrant Shares in the name of the undersigned or in such other name as is specified below:

   

  _______________________________

   

  The Warrant Shares shall be delivered to the following
    DWAC Account Number:

   

  _______________________________

   

  _______________________________

   

  _______________________________

   

  [SIGNATURE OF HOLDER]

   

  	Name of Investing Entity:	 

   

  	Signature of Authorized Signatory of Investing Entity:	 

   

  	Name of Authorized Signatory:	 

   

  	Title of Authorized Signatory:	 

   

  	Date:	 

   

  
  
    	 	 	 

  

  
     

  

  
    

  ASSIGNMENT FORM

   

  (To assign the foregoing
      Warrant, execute this form and supply the required information. Do not use this form to purchase shares.)

   

  FOR VALUE RECEIVED, the foregoing
    Warrant and all rights evidenced thereby are hereby assigned to

   

  	Name:	 	 
	 	(Please Print)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	(Please Print)	 
	 	 	 
	Phone Number:	 	 
	 	 	 
	Email Address:	 	 
	 	 	 
	Dated: _______________ __, ______	 	 
	 	 	 
	Holder’s Signature: ______________________	 	 
	 	 	 
	Holder’s Address: _______________________Exhibit 4.5

   

  FORM OF CLASS A COMMON SHARE PURCHASE WARRANT

   

  UNITED MARITIME CORPORATION

   

  	Warrant Shares: 

        	Issue Date:                      

        

  CUSIP: 

  

  ISIN: 

  

   

  THIS CLASS A COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________, or its assigns (the “Holder”)

    is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on                       (the “Termination Date”)
    but not thereafter, to subscribe for and purchase from United Maritime Corporation, a Marshall Islands corporation (the “Company”), up to                       Common Shares (as subject to adjustment hereunder, the “Warrant Shares”).  The
    purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust
    Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case
    this sentence shall not apply.

   

  Section 1.              Definitions.  In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings
    indicated in this Section 1.

   

  “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
    common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

   

  “Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
    listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a
    Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as
    applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
    prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the
    Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

   

  “Board of Directors” means the board of directors for the Company.

   

  “Business Day” means  any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or
    required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar
    orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
    are open for use by customers on such day.

   

  
  
    	 	 	 

  

  
     

  

  
    

  “Commission” means the United States Securities and Exchange Commission.

   

  “Common Shares” means common shares of the Company, par value $0.0001 per share, and any other class of securities into which such
    securities may hereafter be reclassified or changed.

   

  “Common Share Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any
    time Common Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
    Common Shares.

   

  “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

   

  “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
    liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

   

  “Purchase Agreement” means the Securities Purchase Agreement, dated as of July 18, 2022 among the Company and certain purchasers signatory
    thereto, as amended, modified or supplemented from time to time in accordance with its terms.

   

  “Registration Statement” means the Company’s registration statement on Form F-1 (File No. 333-266099).

   

  “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

   

  “Subsidiary” means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where applicable, also
    include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.

   

  “Trading Day” means a day on which the Common Shares are traded on a Trading Market.

   

  “Trading Market” means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in
    question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).

   

  “Transfer Agent” means American Stock Transfer & Trust Company, LLC, the current transfer agent of the Company with a mailing address
    of 6201 15th Avenue, Brooklyn, New York 11219, and any successor transfer agent of the Company.

     

  “VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
    listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
    (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB
    or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions
    of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest
    of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

   

  
  
    	 	 	 

  

  
     

  

  
    

  “Warrant Agency Agreement” means that certain warrant agency agreement, dated on or about the Issue Date, between the Company and the
    Warrant Agent.

   

  “Warrant Agent” means the Transfer Agent or its affiliate that acts as warrant agent and any successor warrant agent of the Company.

   

  “Warrants” means this Warrant and other Common Share purchase warrants issued by the Company pursuant to the Registration Statement.

   

  Section 2.              Exercise.

   

  a)              Exercise of Warrant.  Subject to the provisions of Section 2(e) hereof, exercise of the purchase rights represented by
    this Warrant may be made, in whole or in part, at any time or times on or after the Issue Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of
    Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the
    date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer unless the cashless exercise procedure specified in Section 2(c) below is specified in
    the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the
    contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
    surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total
    number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
    maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by
    acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time
    may be less than the amount stated on the face hereof.

   

  Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s)
    representing this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing
    corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder’s right to elect to receive a
    Definitive Certificate pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply. The Company hereby acknowledges and agrees that, with respect to a holder whose interest in this Warrant is a beneficial
    interest, upon delivery of irrevocable instructions to such holder’s DTC Participant to exercise such warrants, that solely for purposes of Regulation SHO that such holder shall be deemed to have exercised such warrants. Notwithstanding anything to the
    contrary contained herein, a beneficial holder of the Warrant shall have all of the rights and remedies of the “Holder” hereunder.

   

  
  
    	 	 	 

  

  
     

  

  
    

  b)            Exercise Price.  The exercise price per Common Share under this Warrant shall be $3.25, subject to adjustment hereunder (the “Exercise

      Price”).

   

  c)            Cashless Exercise.  If at the time of exercise hereof, there is no effective registration statement registering, or the
    prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to
    receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

   

  (A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
    both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule
    600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading
    hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice
    of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

   

  (B) = the Exercise Price of this Warrant, as adjusted hereunder; and

   

  (X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
    by means of a cash exercise rather than a cashless exercise.

   

  If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in
      accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrant being exercised. The Company agrees not to take any position contrary to this Section 2(c).

   

  Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
    pursuant to this Section 2(c).

   

  
  
    	 	 	 

  

  
     

  

  
    

  d)            Mechanics of Exercise.

   

  i.             Delivery of Warrant Shares Upon Exercise.  The Company shall cause the Warrant Shares purchased hereunder to be
    transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a
    participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and
    otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
    by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company or the Warrant Agent of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in
    the instance of a cashless exercise) is received by the Company one (1) Trading Day prior to such second Trading Day after the delivery of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company
    and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company or the Warrant Agent of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of a
    cashless exercise) is received by the Company one (1) Trading Day prior to such number of Trading Days comprising the Standard Settlement Period after the delivery of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon
    delivery of the Notice of Exercise, the Holder shall be deemed, solely for purposes of Regulation SHO under the Securities Act, to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
    irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading
    Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver or cause the delivery to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share
    Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice of
    Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
    such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period,
    expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.

   

  ii.             Delivery of New Warrants Upon Exercise.  If this Warrant shall have been exercised in part, the Company shall, at
    the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver or cause the Warrant Agent to deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
    unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

   

  iii.          Rescission Rights.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
    pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

   

  
  
    	 	 	 

  

  
     

  

  
    

  iv.            Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise.  In addition to any other
    rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery
    Date (other than as a result of failure of the Holder to timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a cashless exercise), and if after such date the Holder is required by its broker to purchase (in
    an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”),
    then the Company shall (A) provided that such price set forth in (y)(2) of this clause (A) is on market terms, pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for
    the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
    giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be
    deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Shares having a total
    purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
    sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such
    loss.  Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s
    failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.

   

  v.            No Fractional Shares or Scrip.  No fractional shares or scrip representing fractional shares shall be issued upon
    the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round down to the next whole share.

   

  vi.           Charges, Taxes and Expenses.  Issuance of Warrant Shares shall be made without charge to the Holder for any issue
    or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as
    may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form
    attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for
    same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

   

  
  
    	 	 	 

  

  
     

  

  
    

  vii.          Closing of Books.  The Company will not close its shareholder books or records in any manner which prevents the
    timely exercise of this Warrant, pursuant to the terms hereof.

   

  e)           Holder’s Exercise Limitations.  The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
    to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates,
    and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes
    of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination
    is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
    exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
    contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  For purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
    regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
    schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
    with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this
    Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the
    Company shall have no obligation to verify or confirm the accuracy of such determination, and a submission of a Notice of Exercise shall be deemed a representation and warranty by the Holder of the foregoing determination.   In addition, a
    determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of
    outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the
    Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.  Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in
    writing to the Holder the number of Common Shares then outstanding.  In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
    Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was reported.  The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by the Holder prior to the issuance of any
    Warrants, 9.99%) of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant.  The Holder may, upon notice to the Company, increase or decrease the Beneficial
    Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares upon
    exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this
    paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
    limitations contained in this paragraph shall apply to a successor holder of this Warrant.

   

  
  
    	 	 	 

  

  
     

  

  
    

  Section 3.              Certain Adjustments.

   

  a)            Share Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or
    otherwise makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of
    this Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Common Shares into a smaller number of shares or (iv) issues by reclassification of the Common
    Shares any share capital of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event
    and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
    Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become
    effective immediately after the effective date in the case of a subdivision, combination or re-classification.

   

  b)            Subsequent Rights Offerings.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
    issues or sells any Common Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to all record holders of any class of Common Shares (the “Purchase Rights”), then the Holder will be entitled to acquire,
    upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any
    limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date
    as of which the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would
    result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right to such
    extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

   

  c)            Pro Rata Distributions.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
    other distribution of its assets (or rights to acquire its assets) pro rata to all holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or
    options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) except for any recurring cash dividend or to the extent an adjustment was already made pursuant to Section 3(a) (a
    “Distribution”), then the Exercise Price shall be decreased, effective immediately after the effective date of such Distribution, by the amount of cash and/or the fair market value (as determined by the Company’s Board of Directors, in good faith) of
    any securities or other assets paid on each Common Share in respect of such Distribution in order that subsequent thereto upon exercise of the Warrants the Holder may obtain the equivalent benefit of such Distribution.

   

  
  
    	 	 	 

  

  
     

  

  
    

  d)            Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
    more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, other than in the ordinary course of business, effects
    any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, except to the extent subject to an adjustment pursuant to Section 3(a), (b) or (c),
    (iii) any, direct or indirect, purchase offer, tender offer or exchange offer by the Company is completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has
    been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any
    compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or
    share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires
    more than 50% of the outstanding Common Shares (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such
    exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring
    corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of Common Shares for which this
    Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  For purposes of any such exercise, the determination of the Exercise Price shall be
    appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
    Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Shares are given any choice as to the securities, cash or property to be received in a
    Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  Notwithstanding anything to the contrary, in the event of a
    Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date
    of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this
    Warrant on the date of the consummation of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall
    only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
    portion of this Warrant, that is being offered and paid to the holders of Common Shares of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, shares or any combination thereof, or whether the
    holders of Common Shares are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Shares of the Company are not offered or
    paid any consideration in such Fundamental Transaction, such holders of Common Shares will be deemed to have received common shares of the Successor Entity (which Entity may be the Company following such Fundamental Transaction). “Black Scholes
      Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and
    reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility
    equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the
    underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)
    the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day
    of the Holder’s request pursuant to this Section 3(d), (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.  The
    payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder’s election (or, if later, on the date of consummation of the Fundamental Transaction). The Company shall cause any
    successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d)
    pursuant to written agreements in form and substance reasonably satisfactory to and approved by the Holders holding Warrants to purchase at least a majority of the Common Shares underlying the then outstanding Warrants (without unreasonable delay)
    prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
    Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any
    limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the Common Shares
    pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the
    consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holders holding Warrants to purchase at least a majority of the Common Shares underlying the then outstanding Warrants. Upon the occurrence
    of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the
    Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

   

  e)            Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
    case may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.

   

  
  
    	 	 	 

  

  
     

  

  
    

  f)            Notice to Holder.

   

  i.              Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
    the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
    requiring such adjustment.

   

  ii.             Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
    form) on the Common Shares, except for any recurring cash dividend (B) the Company shall declare a redemption of the Common Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or
    purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Common Shares, any consolidation or merger to which the Company
    (and its Subsidiaries, taken as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E)
    the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number
    or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
    purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants
    are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares of record
    shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect
    therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
    regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on
    the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

   

  (g)           Voluntary Adjustment by Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during
    the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

   

  
  
    	 	 	 

  

  
     

  

  
    

  Section 4.              Transfer of Warrant.

   

  a)            Transferability.  This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant
    at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
    taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or
    denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  Notwithstanding anything herein to the
    contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of
    the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.  The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
    Warrant issued.

   

  b)            New Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided
    or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or
    attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or
    combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

   

  c)            Warrant Register. The Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate (as defined in the
    Warrant Agency Agreement), the Company) shall register this Warrant, upon records to be maintained by the Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate, the Company) for that purpose (the “Warrant Register”),
    in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
    and for all other purposes, absent actual notice to the contrary.

   

  Section 5.              Miscellaneous.

   

  a)            No Rights as Shareholder Until Exercise; No Settlement in Cash.  This Warrant does not entitle the Holder to any voting rights,
    dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless
    exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

   

  b)            Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of an affidavit of
    loss reasonably satisfactory to the Company evidencing the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
    satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share
    certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.

   

  c)            Saturdays, Sundays, Holidays, etc.  If the last or appointed day for the taking of any action or the expiration of any right
    required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

   

  
  
    	 	 	 

  

  
     

  

  
    

  d)            Authorized Shares.

   

  The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a
    sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
    who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
    provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the
    purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
    from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

   

  Except and to the extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant
    Shares underlying such Warrants), the Company shall not by any action, including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
    securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
    as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
    amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
    upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
    its obligations under this Warrant.

   

  Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
    Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

   

  e)            Governing Law.  All questions concerning the construction, validity, enforcement and
      interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.

   

  
  
    	 	 	 

  

  
     

  

  
    

  f)             Jurisdiction; Agent for Process. Each party agrees that all legal proceedings concerning
      the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
      commenced exclusively in the state and federal courts sitting in the City of New York.  Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the
      adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
      personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being
      served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that,
      subject to applicable law, such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If
      either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs
      and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it has appointed Watson Farley & Williams LLP, with a business address at 250 West 55th Street, 31st
    Floor, New York, NY 10019, as its authorized agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Warrant or the transactions
      contemplated herein which may be instituted in any New York federal or state court, by a Holder, the directors, officers, partners, employees and agents of such Holder and each affiliate of such Holder, and expressly accept the non-exclusive
      jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the
      Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to
      accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint,
      without unreasonable delay, another such agent in the United States, and notify the Holders of such appointment. Notwithstanding the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a
      claim under the federal securities laws. This paragraph shall survive any termination of this Warrant, in whole or in part. 

    

  g)            Restrictions.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered
    and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

   

  h)            Nonwaiver and Expenses.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
    shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies.  Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
    which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate
    proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

   

  i)             Notices.  Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
    limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized overnight courier service, addressed to:

   

  If to the Warrant Agent

   

  American Stock Transfer & Trust Company, LLC

  6201 15th Avenue

  Brooklyn, New York 11219

  Attention: Reorg Department - Warrants

  Email address: reorg_warrants@astfinancial.com

   

  
  
    	 	 	 

  

  
     

  

  
    

  If to the Company

   

  United Maritime Corporation

  c/o 154 Vouliagmenis Avenue

  166 74 Glyfada

  Greece

  Tel: + 30-2130181507

  Email: legal@usea.gr

  Facsimile: +302109638404

  Attn: General Counsel

   

  or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other
    communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number,
    e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (a) the time of transmission, if such notice or
    communication is delivered via facsimile at the facsimile number or e-mail (or e-mail attachment) at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading
    Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail (or e-mail attachment) at the e-mail address as set forth on the signature pages attached hereto on a day that is not a
    Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom
    such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
    Commission pursuant to a Current Report on Form 6-K.

   

  j)             Limitation of Liability.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
    to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is
    asserted by the Company or by creditors of the Company.

   

  k)            Remedies.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
    be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to
    waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

   

  l)             Successors and Assigns.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
    shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time
    of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

   

  m)           Amendment.  Any Warrant held in the form of a Definitive Certificate may be modified or amended or the provisions hereof waived
    with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.

   

  
  
    	 	 	 

  

  
     

  

  
    

  n)            Severability.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
    valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such
    provisions or the remaining provisions of this Warrant.

   

  o)            Headings.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
    deemed a part of this Warrant.

   

  p)            Warrant Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is
    issued subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling. Any reference to the
    Company is also deemed to refer to the Warrant Agent, unless otherwise specified or the context otherwise requires.

   

  ********************

   

  (Signature Page Follows)

   

  
  
    	 	 	 

  

  
     

  

  
    

  IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
    indicated.

   

  	 	UNITED MARITIME CORPORATION
	 	 
	 	By:	 
	 	 	Name: Stamatios Tsantanis
	 	 	Title: Chairman and Chief Executive Officer

   

  
  
    	 	 	 

  

  
     

  

  
    

  NOTICE OF EXERCISE

   

  TO:         UNITED MARITIME CORPORATION

   

  (1)       The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
    required if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

   

  (2)       Payment shall take the form of (check applicable box):

   

   ̈ in lawful money of the United States; or

   

   ̈ if permitted the cancellation of such number of Warrant Shares as is necessary,
      in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

   

  (3)       Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

   

  The Warrant Shares shall be delivered to the following DWAC Account Number:

   

  	DTC number:	 	 
	 	 	 
	Account name:	 	 
	 	 	 
	Account number:	 	 

   

  [SIGNATURE OF HOLDER]

   

  	Name of Investing Entity:	 
	 	 
	Signature of Authorized Signatory of Investing Entity:	 
	 	 
	Name of Authorized Signatory:	 

   

  	Title of Authorized Signatory:	 
	 	 
	Date:	 

   

  
  
    	 	 	 

  

  
     

  

  
    

  EXHIBIT B

  ASSIGNMENT FORM

   

  (To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)

   

  FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

   

  	Name:	 
	 	(Please Print)
	 	 
	Address:	 
	 	(Please Print)
	 	 
	Phone Number:	 
	 	 
	Email Address:	 
	 	 
	Dated: _______________ __, ______	 
	 	 
	Holder’s Signature: _______________	 
	 	 
	Holder’s Address: _______________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]